Davidson Kempner Capital Management’s BioPlus Acquisition Corp. Warrants BIOSW Stock Holding History

Davidson Kempner Capital Management’s Portfolio BIOSW Stock Details BIOSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-250,000	Closed	-$14K	–	325
2023 Q3	$14K	Hold	250,000	–	–	﹤0.01%	224
2023 Q2	$32.2K	Hold	250,000	–	–	﹤0.01%	210
2023 Q1	$20K	Hold	250,000	–	–	﹤0.01%	291
2022 Q4	$3K	Hold	250,000	–	–	﹤0.01%	409
2022 Q3	$22K	Hold	250,000	–	–	﹤0.01%	412
2022 Q2	$20K	Hold	250,000	–	–	﹤0.01%	465
2022 Q1	$55K	Buy	+250,000	New	+$64.9K	﹤0.01%	499

Davidson Kempner Capital Management's BIOSW Position: Q4 2023 in Review

Davidson Kempner Capital Management sold out of BioPlus Acquisition Corp. Warrants (BIOSW) in Q4 2023, closing a stake of 250,000 shares — an estimated $14K sold.

Davidson Kempner Capital Management first reported a position in BIOSW in Q1 2022 and held it in 7 quarters. The position peaked at $55K in Q1 2022. 0 funds tracked by Wall St. Rank hold BIOSW as of Q4 2023.

Davidson Kempner Capital Management reported no remaining BioPlus Acquisition Corp. Warrants position as of Q4 2023 after selling out during the quarter.
Davidson Kempner Capital Management sold 250,000 BioPlus Acquisition Corp. Warrants shares in Q4 2023, an estimated $14K.
Davidson Kempner Capital Management first reported a position in BioPlus Acquisition Corp. Warrants in Q1 2022 and held it in 7 quarters.
Davidson Kempner Capital Management's BioPlus Acquisition Corp. Warrants position peaked at $55K in Q1 2022.
0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Warrants as of Q4 2023.

Based on Davidson Kempner Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.